We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
what's L2 looking like ?...
This is Bonkers !!
MM's must be seriously holding this back now.
Lots of buys not showing up.
Watch any big delayed trades after hours over the coming days… :-)
Front whichever angle you look at it’s it’s a monster deal...upto $703m! Don’t know what the MMs are upto but soon they gonna have to let this go!
Wait till the yanks get in on this
Biggest milestone payments I've ever seen on here!
Massive friggin deal!
Their buy @79p a share buys them a board seat in SLN... so they won't sell
Worth over £3 if not more
$2 Billion potential....
Mcap is how much ???
£90 Million.
20 bags please !
Can’t decide whether to buy at this price or wait for the retrace?
Just listening to the conference call and it's additional potential milestone payment of $703 million per additional asset of which we have two so just over $1.4 billion!! That's on top of the $563m for SLN 500, so nearly $2 billion potentially in total!
They are holding this back to fill big orders I think.
They are hiding a lot of trades. My £6k buy isn’t showing
Unfortunately not a holder here but wow, fantastic deal for SLN - well done to them and to all holders.
It was at £3.00 a few years back, but this news is a company game changer !
Silence Call with Investors
Dr. David Horn Solomon, Chief Executive Officer of Silence Therapeutics, will host a conference call accompanied by a live presentation for analysts and investors today at 13.00pm BST (8.00am EDT). Link to the live webcast: https://edge.media-server.com/mmc/p/d4noa4jd. Dial-in details are: Participant UK dial-in: +44 (0) 2071 928000; Participant; US Dial-in: +1 631 510 7495 Conference ID: 1576453. A presentation to accompany the call will be made available to download from https://www.silence-therapeutics.com/investors/results-reports-presentations.
Any idea where this can go?
Can’t believe the generosity of MMs..makes a change! For holding this price for Now over 30min..
"We are very excited by the significant potential offered by Silence's RNAi technology to meet the needs of underserved patients in a number of serious and critical conditions, and we look forward to collaborating with them to advance development of complement-targeted assets as new therapeutic options," said Steven Romano, M.D., Chief Scientific Officer and Executive Vice President of Mallinckrodt.
Mallinckrodt has agreed to provide Silence with an upfront payment of $20 million. Silence is also eligible to receive up to $10 million in research milestones for SLN500 and for each optioned asset, in addition to funding for Phase 1 clinical development including GMP[4] manufacturing. Silence will fund all other preclinical activities. The collaboration provides for potential added clinical and regulatory milestone payments of up to $100 million for SLN500, as well as commercial milestone payments of up to $563 million for SLN500. Should Mallinckrodt opt to license one or two additional assets, Silence could receive up to $703 million in similar clinical, regulatory, and commercial milestone payments per asset. Silence would also receive tiered, low double-digit to high-teen royalties on net sales for SLN500 and each optioned asset.
'Watch and learn ' - presentation about to start; should be more interesting than the tour de france.
LONDON and STAINES-UPON-THAMES, United Kingdom, July 18, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, and Silence Therapeutics plc (LON: SLN), a leader in the discovery, development and delivery of novel RNA[2] interference (RNAi) therapeutics for the treatment of serious diseases, today announced a collaboration that will allow the companies to develop and commercialize RNAi drug targets designed to inhibit or 'silence' the complement cascade, a group of proteins that are involved in the immune system and that play a role in the development of inflammation. These proteins are known to contribute to the pathogenesis of many diseases, including autoimmune diseases.
SILENCE THERAPEUTICS AND Mallinckrodt ANNOUNCE collaboration TO DEVELOP AND COMMERCIALIZE RNAi THERAPEUTICS FOR COMPLEMENT-MEDIATED DISEASES
-- Collaboration advances Silence's proprietary platform in the growing field of RNAi technology
-- Agreement provides Mallinckrodt with an exclusive worldwide license for one preclinical asset that targets a specific protein in the complement pathway, C3 (SLN500), and an option for up to two additional assets with different complement protein targets
-- Silence to receive a $20 million upfront payment, potential near- and long-term development and commercial milestones, and royalties on net sales
-- Silence will host a webinar today at 1:00 p.m. BST[1] to discuss the announcement
Watch and learn in that case..
My only concern is that they bought @79p.....
Market out for lunch, don’t miss conf call in 15min..for bod to explain the enormity of this deal.gla